Protocol Development Grant – pancreatic ductal adenocarcinoma (PDAC)
Funder(s): Anticancer Fund,This grant opportunity seeks to encourage academic researchers to advance their preclinical discoveries into clinical studies.
We are looking for interventions with sound preclinical data in pancreatic ductal adenocarcinoma that is mature enough to be taken forward into a clinical trial.
The aim of the grant is to aid investigators in developing and transforming their preclinical results into a high-quality clinical trial by providing seed funding to develop the protocol.
Timeline & Milestones
Call Open
June 13, 2024
Deadline Full Application
October 1, 2024
Grant Decision – Final Decision – Awarding
December 31, 2024